Literature DB >> 3523800

Low flow venovenous bypasses in small dogs and pediatric patients undergoing replacement of the liver.

I Kam, S Lynch, S Todo, A Dewolf, F McSteen, F Jakab, B G Ericzon, S Takaya, T E Starzl.   

Abstract

A venovenous bypass for transplantation of the liver was developed and evaluated in dogs and applied clinically, with flows that averaged less than 500 milliliters per minute. Fatal pulmonary emboli were seen in two of 40 experiments. The venovenous flow in the four pediatric recipients was 200 to 1,200 milliliters per minute, and there were no complications.

Entities:  

Mesh:

Year:  1986        PMID: 3523800      PMCID: PMC2677019     

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  6 in total

1.  Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow.

Authors:  T E STARLZ; H A KAUPP; D R BROCK; R E LAZARUS; R V JOHNSON
Journal:  Surg Gynecol Obstet       Date:  1960-12

2.  VENO-VENOUS BYPASS WITHOUT SYSTEMIC ANTICOAGULATION IN CANINE AND HUMAN LIVER TRANSPLANTATION.

Authors:  Scot W Denmark; Byers W Shaw; Thomas E Starzl; Bartley P Griffith
Journal:  Surg Forum       Date:  1983

3.  [Experimental orthopic liver transplant].

Authors:  J Carlos Cutropia; F Coratolo; A Spinetta; J Keil; A Ribas; L Assíni; G Delle Donne; M Bianchi; A Gui Názu; J A Verdaguer
Journal:  Rev Esp Enferm Apar Dig       Date:  1972-11-01

4.  Veno-venous bypass without systemic anticoagulation for transplantation of the human liver.

Authors:  B P Griffith; B W Shaw; R L Hardesty; S Iwatsuki; H T Bahnson; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1985-03

5.  Orthotopic liver transplantation with the assistance of an external shunt and a nonpulsatile perfusion pump.

Authors:  L H Toledo-Pereyra; G H MacKenzie
Journal:  Transplantation       Date:  1983-01       Impact factor: 4.939

6.  Venous bypass in clinical liver transplantation.

Authors:  B W Shaw; D J Martin; J M Marquez; Y G Kang; A C Bugbee; S Iwatsuki; B P Griffith; R L Hardesty; H T Bahnson; T E Starzl
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

  6 in total
  11 in total

1.  Factors in the Development of Liver Transplantation.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; R D Gordon; C Esquivel; S Todo; I Kam; S Lynch
Journal:  Transplant Proc       Date:  1985-10       Impact factor: 1.066

2.  Comparison of UW with other solutions for liver preservation in dogs.

Authors:  S Todo; L Podesta; Y Ueda; O Imventarza; A Casavilla; A Oks; K Okuda; M Nalesnik; R Venkataramanan; T E Starzl
Journal:  Clin Transplant       Date:  1989-10       Impact factor: 2.863

3.  Refinements in the surgical technique of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; C O Esquivel; S Todo; I Kam; S Lynch; R D Gordon; B W Shaw
Journal:  Semin Liver Dis       Date:  1985-11       Impact factor: 6.115

Review 4.  Progress in liver transplantation.

Authors:  R D Gordon; S Iwatsuki; C O Esquivel; L Makowka; S Todo; A G Tzakis; J W Marsh; T E Starzl
Journal:  Adv Surg       Date:  1988

5.  Functional deterioration of the liver by elevated inferior vena cava pressure: a proposed upper safety limit of pressure for maintaining liver viability in dogs.

Authors:  H Higashiyama; M Yamaguchi; K Kumada; H Sasaki; T Yamaguchi; K Ozawa
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

6.  Complications of venous reconstruction in human orthotopic liver transplantation.

Authors:  J Lerut; A G Tzakis; K Bron; R D Gordon; S Iwatsuki; C O Esquivel; L Makowka; S Todo; T E Starzl
Journal:  Ann Surg       Date:  1987-04       Impact factor: 12.969

7.  Advantages of venous bypass during orthotopic transplantation of the liver.

Authors:  B W Shaw; D J Martin; J M Marquez; Y G Kang; A C Bugbee; S Iwatsuki; B P Griffith; R L Hardesty; H T Bahnson; T E Starzl
Journal:  Semin Liver Dis       Date:  1985-11       Impact factor: 6.115

8.  Pancreatic hormones and amino acid levels following liver transplantation.

Authors:  A Francavilla; L Polimeno; D H Van Thiel; S Todo; I Kam; S Lynch; T E Starzl
Journal:  Hepatology       Date:  1987 Sep-Oct       Impact factor: 17.425

9.  Canine liver transplantation under Nva2-cyclosporine versus cyclosporine.

Authors:  S Todo; K A Porter; I Kam; S Lynch; R Venkataramanan; A DeWolf; T E Starzl
Journal:  Transplantation       Date:  1986-03       Impact factor: 4.939

10.  Sodium lactobionate sucrose solution for canine liver and kidney preservation.

Authors:  Y Zhu; H Furukawa; K Nakamura; I Hamamoto; Y Wu; R Xiaoshan; R Venkataramanan; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.